company background image
CNTM.F logo

Cansortium OTCPK:CNTM.F Stock Report

Last Price

US$0.21

Market Cap

US$62.9m

7D

-2.3%

1Y

162.5%

Updated

28 Mar, 2024

Data

Company Financials +

Cansortium Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cansortium
Historical stock prices
Current Share PriceUS$0.21
52 Week HighUS$0.29
52 Week LowUS$0.058
Beta3.11
1 Month Change15.38%
3 Month Change136.06%
1 Year Change162.50%
3 Year Change-72.36%
5 Year Changen/a
Change since IPO-88.19%

Recent News & Updates

Recent updates

Shareholder Returns

CNTM.FUS PharmaceuticalsUS Market
7D-2.3%1.2%0.4%
1Y162.5%25.8%28.8%

Return vs Industry: CNTM.F exceeded the US Pharmaceuticals industry which returned 25.8% over the past year.

Return vs Market: CNTM.F exceeded the US Market which returned 28.8% over the past year.

Price Volatility

Is CNTM.F's price volatile compared to industry and market?
CNTM.F volatility
CNTM.F Average Weekly Movement16.1%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: CNTM.F's share price has been volatile over the past 3 months.

Volatility Over Time: CNTM.F's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2018n/aRobert Beasleyhttps://getfluent.com

Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company’s medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products.

Cansortium Inc. Fundamentals Summary

How do Cansortium's earnings and revenue compare to its market cap?
CNTM.F fundamental statistics
Market capUS$62.90m
Earnings (TTM)-US$33.50m
Revenue (TTM)US$95.21m

0.7x

P/S Ratio

-1.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CNTM.F income statement (TTM)
RevenueUS$95.21m
Cost of RevenueUS$53.05m
Gross ProfitUS$42.16m
Other ExpensesUS$75.66m
Earnings-US$33.50m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin44.28%
Net Profit Margin-35.19%
Debt/Equity Ratio386.5%

How did CNTM.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.